Yong et al. showed that the silencing of MALAT1 resulted in reduced serum levels of IL-6, IL-8, tumor necrosis factor (TNF)-α, skeletal muscle cell apoptosis, and AKT-1 phosphorylation, indicating a promising therapeutic option for sepsis [22]. The gene discussed is TNF; the disease is Sepsis.